SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-146166
Filing Date
2020-05-19
Accepted
2020-05-19 16:20:40
Documents
14
Period of Report
2020-05-19
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d935012d8k.htm   iXBRL 8-K 32913
2 EX-99.1 d935012dex991.htm EX-99.1 9181
6 GRAPHIC g935012g0519075537102.jpg GRAPHIC 2885
  Complete submission text file 0001193125-20-146166.txt   170258

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20200519.xsd EX-101.SCH 3058
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20200519_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20200519_pre.xml EX-101.PRE 10945
14 EXTRACTED XBRL INSTANCE DOCUMENT d935012d8k_htm.xml XML 3277
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 20893879
SIC: 2834 Pharmaceutical Preparations